Literature DB >> 8602752

The insulin-like growth factor I system in cerebellar degeneration.

I Torres-Aleman1, V Barrios, A Lledo, J Berciano.   

Abstract

Brain insulin-like growth factor I (IGF-I) and its related molecules may be involved in neurodegenerative processes in which IGF-I-containing pathways are compromised. Since IGF-I is present in the olivocerebellar circuitry, two types of late-onset cerebellar ataxias (olivopontocerebellar and idiopathic cerebellar cortical atrophy) were chosen to test this hypothesis. The following significant changes in the peripheral IGF-I system of these patients were found: low IGF-I levels, and high IGF-binding protein 1 (BP-1), and BP-3 affinity for IGF-1. Sixty percent of the patients also had significantly low insulin levels. Patients suffering from other neurological diseases with cerebellar dysfunction and ataxia not involving the olivocerebellar pathway also had low IGF-I levels, while IGFBPs and insulin levels were normal. Our data indicate that degeneration of an IGF-I-containing neuronal pathway produces significant changes in the peripheral IGF system. This suggests strongly that the endocrine (bloodborne) and the paracrine/autocrine (brain) IGF systems are linked functionally. We propose that alterations in the blood IGF-I system may constitute a marker of some cerebellar diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8602752     DOI: 10.1002/ana.410390310

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

Review 1.  Extended longevity mechanisms in short-lived progeroid mice: identification of a preservative stress response associated with successful aging.

Authors:  Marieke van de Ven; Jaan-Olle Andressoo; Valerie B Holcomb; Paul Hasty; Yousin Suh; Harry van Steeg; George A Garinis; Jan H J Hoeijmakers; James R Mitchell
Journal:  Mech Ageing Dev       Date:  2006-11-28       Impact factor: 5.432

Review 2.  Serum growth factors and neuroprotective surveillance: focus on IGF-1.

Authors:  I Torres-Aleman
Journal:  Mol Neurobiol       Date:  2000-06       Impact factor: 5.590

3.  Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia.

Authors:  A M Fernandez; A G de la Vega; I Torres-Aleman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 4.  Brain repair and neuroprotection by serum insulin-like growth factor I.

Authors:  Eva Carro; Jose Luis Trejo; Angel Núñez; Ignacio Torres-Aleman
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

5.  Cross-talk between IGF-1 and estrogen receptors attenuates intracellular changes in ventral spinal cord 4.1 motoneuron cells because of interferon-gamma exposure.

Authors:  Sookyoung Park; Kenkichi Nozaki; Joshua A Smith; James S Krause; Naren L Banik
Journal:  J Neurochem       Date:  2013-12-04       Impact factor: 5.372

Review 6.  Role of insulin-like growth factor I signaling in neurodegenerative diseases.

Authors:  José Luis Trejo; Eva Carro; Eva Garcia-Galloway; Ignacio Torres-Aleman
Journal:  J Mol Med (Berl)       Date:  2003-11-28       Impact factor: 4.599

Review 7.  Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children.

Authors:  Raili Riikonen
Journal:  Int J Mol Sci       Date:  2017-09-26       Impact factor: 5.923

8.  IGF-1 in Friedreich's Ataxia - proof-of-concept trial.

Authors:  Irene Sanz-Gallego; Ignacio Torres-Aleman; Javier Arpa
Journal:  Cerebellum Ataxias       Date:  2014-07-04

9.  IGF-1 in autosomal dominant cerebellar ataxia - open-label trial.

Authors:  Irene Sanz-Gallego; Francisco J Rodriguez-de-Rivera; Irene Pulido; Ignacio Torres-Aleman; Javier Arpa
Journal:  Cerebellum Ataxias       Date:  2014-10-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.